Download PDF
J Pediatr Intensive Care
DOI: 10.1055/s-0042-1758479
Review Article

The Role of Presepsin as a Biomarker of Sepsis in Children: A Systemic Review and Meta-Analysis

Daisy Khera
1   Department of Paediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
,
Nisha Toteja
2   Department of Paediatrics, All India Institute of Medical Sciences, Gorakhpur, Uttar Pradesh, India
,
Simranjeet Singh
1   Department of Paediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
,
Siyaram Didel
1   Department of Paediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
,
Kuldeep Singh
1   Department of Paediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
,
Ankita Chugh
3   Department of Dentistry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
,
Surjit Singh 
4   Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Objectives Biomarkers in sepsis are an arena of avid research as they can facilitate timely diagnosis and help reduce mortality. Presepsin is a promising candidate with good diagnostic performance reported in adult and neonatal studies. However, there is no clear consensus about its utility in the pediatric age group. This study aimed to synthesize scientific evidence regarding the diagnostic and prognostic performance of presepsin in pediatric sepsis.

Data Sources A systematic literature search was conducted in MEDLINE/PubMed, Cochrane Central Register of Clinical Trials, Google Scholar, and Scopus to identify relevant studies reporting the diagnostic and prognostic accuracy of presepsin.

Study Selection Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we retrieved all controlled trials and observational studies on presepsin as a biomarker in children aged <19 years with sepsis.

Data Extraction Two authors independently performed study screening, data extraction, and quality assessment of the included studies.

Data Synthesis Among the 267 citations identified, a total of nine relevant studies were included in the final analysis. The pooled diagnostic sensitivity and specificity of presepsin were 0.99 (95% confidence interval [CI]; 0.97–1.00) and 0.88 (95% CI; 0.83–0.92), respectively, with a diagnostic odds ratio (DOR) of 28.15 (95% CI; 0.74–1065.67) and area under the curve (AUC) in summary receiver operating curve of 0.89. Prognostic accuracy for presepsin had a sensitivity of 0.64 (95% CI; 0.35–1.0), specificity of 0.62 (95% CI; 0.44–0.87), and DOR of 3.3 (95% CI; 0.20–53.43). For procalcitonin, the pooled sensitivity for diagnostic accuracy was 0.97 (95% CI; 0.94–1.00), specificity was 0.76 (95% CI; 0.69–0.82), DOR was 10.53 (95% CI; 5.31–20.88), and AUC was 0.81.

Conclusion Presepsin has good diagnostic accuracy with high sensitivity and specificity. Its prognostic accuracy in predicting mortality is low.

Keywords

sepsis - presepsin - diagnosis - meta-analysis - children - sensitivity - specificity

Clinical Trial Registration

Not applicable.


Ethical Approval and Consent to Participate

Not Applicable.


Consent for Publication

Not applicable.


Availability of Supporting Data

The datasets used and/or analyzed during the current study are available from the corresponding author on request.


Authors Contribution

All of the authors were responsible for study design and planning of systematic review; D.K. and S.S.1 were responsible for literature search; SS2 and DK were responsible for figures; D.K., S.S.2, and S.S.1 were responsible for tables; S.S.2 and D.K. were responsible for data collection and analysis; D.K., A.C., S.S.2 were responsible for risk of bias; S.S.2, A.C., and D.K. were responsible for GRADE Analysis; and S.S.2 and D.K. were responsible for data interpretation; N.T., D.K., S.S.2, S.S.1, K.S., S.D., and A.C. were responsible for writing. All of the authors were responsible for resolving queries and corrections and final approval of manuscript. -


Note

The corresponding author attests that all listed authors meet authorship criteria as per ICJME and that the manuscript is an honest, accurate, and transparent account of the study being reported.


Name of the institution where the work was performed:- All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.


Supplementary Material



Publication History

Received: 20 May 2022

Accepted: 28 September 2022

Article published online:
17 November 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Weiss SL, Balamuth F, Hensley J. et al. The epidemiology of hospital death following pediatric severe sepsis: when, why, and how children with sepsis die. Pediatr Crit Care Med 2017; 18 (09) 823-830
    CrossrefPubMedGoogle Scholar
  • 2 Singer M, Deutschman CS, Seymour CW. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315 (08) 801-810
    Google Scholar
  • 3 Chiesa C, Panero A, Osborn JF, Simonetti AF, Pacifico L. Diagnosis of neonatal sepsis: a clinical and laboratory challenge. Clin Chem 2004; 50 (02) 279-287
    CrossrefPubMedGoogle Scholar
  • 4 McWilliam S, Riordan A. How to use: C-reactive protein. Arch Dis Child Educ Pract Ed 2010; 95 (02) 55-58
    CrossrefPubMedGoogle Scholar
  • 5 Pierce R, Bigham MT, Giuliano Jr JS. Use of procalcitonin for the prediction and treatment of acute bacterial infection in children. Curr Opin Pediatr 2014; 26 (03) 292-298
    CrossrefPubMedGoogle Scholar
  • 6 Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013; 13 (05) 426-435
    CrossrefPubMedGoogle Scholar
  • 7 Shirakawa K, Naitou K, Hirose J, Takahashi T, Furusako S. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients. Clin Chem Lab Med 2011; 49 (05) 937-939
    CrossrefPubMedGoogle Scholar
  • 8 Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta 2011; 412 (23-24): 2157-2161
    CrossrefPubMedGoogle Scholar
  • 9 Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother 2011; 17 (06) 764-769
    CrossrefPubMedGoogle Scholar
  • 10 Yoon SH, Kim EH, Kim HY, Ahn JG. Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis. BMC Infect Dis 2019; 19 (01) 760
    CrossrefPubMedGoogle Scholar
  • 11 El Gendy FM, El-Mekkawy MS, Saleh NY, Habib MSE, Younis FE. Clinical study of presepsin and pentraxin3 in critically ill children. J Crit Care 2018; 47: 36-40
    CrossrefPubMedGoogle Scholar
  • 12 Ghazy MM, El-Halaby HA, El-Sabbagh AM. et al. Diagnostic and prognostic values of soluble CD14 (presepsin) in sepsis in pediatric intensive-care patients. Alex J Pediatrics 2018; 31 (03) 141-147
    CrossrefPubMedGoogle Scholar
  • 13 Algebaly H-A, Fouad HM, Elkholy MM. et al. Is presepsin a reliable marker of sepsis diagnosis in pediatric intensive care unit?. Open Access Maced J Med Sci 2020; 8: 66-70
    CrossrefPubMedGoogle Scholar
  • 14 Olad E, Sedighi I, Mehrvar A. et al. Presepsin (scd14) as a marker of serious bacterial infections in chemotherapy induced severe neutropenia. Iran J Pediatr 2014; 24 (06) 715-722
    PubMedGoogle Scholar
  • 15 Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62 (10) 1006-1012
    Google Scholar
  • 16 Whiting PF, Rutjes AWS, Westwood ME. et al; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155 (08) 529-536
    CrossrefPubMedGoogle Scholar
  • 17 Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327 (7414): 557-560
    Google Scholar
  • 18 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21 (11) 1539-1558
    Google Scholar
  • 19 Baraka A, Zakaria M. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies. Int J Hematol 2018; 108 (02) 184-191
    CrossrefPubMedGoogle Scholar
  • 20 Plesko M, Suvada J, Makohusova M. et al. The role of CRP, PCT, IL-6 and presepsin in early diagnosis of bacterial infectious complications in paediatric haemato-oncological patients. Neoplasma 2016; 63 (05) 752-760
    CrossrefPubMedGoogle Scholar
  • 21 Basaranoglu ST, Karadag-Oncel E, Aykac K. et al. Presepsin: a new marker of catheter related blood stream infections in pediatric patients. J Infect Chemother 2018; 24 (01) 25-30
    CrossrefPubMedGoogle Scholar
  • 22 Urbonas V, Eidukaitė A, Tamulienė I. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia. Cytokine 2013; 62 (01) 34-37
    CrossrefPubMedGoogle Scholar
  • 23 Zhu Y, Li X, Guo P, Chen Y, Li J, Tao T. The accuracy assessment of presepsin (sCD14-ST) for mortality prediction in adult patients with sepsis and a head-to-head comparison to PCT: a meta-analysis. Ther Clin Risk Manag 2019; 15: 741-753
    CrossrefPubMedGoogle Scholar
  • 24 Zhang X, Liu D, Liu Y-N, Wang R, Xie LX. The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis. Crit Care 2015; 19: 323
    CrossrefPubMedGoogle Scholar
  • 25 Zhang J, Hu Z-D, Song J, Shao J. Diagnostic value of presepsin for sepsis: a systematic review and meta-analysis. Medicine (Baltimore) 2015; 94 (47) e2158
    CrossrefPubMedGoogle Scholar
  • 26 Wu C-C, Lan H-M, Han S-T. et al. Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis. Ann Intensive Care 2017; 7 (01) 91
    CrossrefPubMedGoogle Scholar
  • 27 Parri N, Trippella G, Lisi C, De Martino M, Galli L, Chiappini E. Accuracy of presepsin in neonatal sepsis: systematic review and meta-analysis. Expert Rev Anti Infect Ther 2019; 17 (04) 223-232
    CrossrefPubMedGoogle Scholar
  • 28 Bellos I, Fitrou G, Pergialiotis V, Thomakos N, Perrea DN, Daskalakis G. The diagnostic accuracy of presepsin in neonatal sepsis: a meta-analysis. Eur J Pediatr 2018; 177 (05) 625-632
    CrossrefPubMedGoogle Scholar
  • 29 Sanders S, Barnett A, Correa-Velez I, Coulthard M, Doust J. Systematic review of the diagnostic accuracy of C-reactive protein to detect bacterial infection in nonhospitalized infants and children with fever. J Pediatr 2008; 153 (04) 570-574
    CrossrefPubMedGoogle Scholar
  • 30 Kondo Y, Umemura Y, Hayashida K, Hara Y, Aihara M, Yamakawa K. Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis. J Intensive Care 2019; 7: 22
    CrossrefPubMedGoogle Scholar
  • 31 Ruan L, Chen G-Y, Liu Z. et al. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review. Crit Care 2018; 22 (01) 316
    Google Scholar
  • 32 Yang HS, Hur M, Yi A, Kim H, Lee S, Kim SN. Prognostic value of presepsin in adult patients with sepsis: Systematic review and meta-analysis. PLoS One 2018; 13 (01) e0191486
    CrossrefPubMedGoogle Scholar